NCT04205344View on ClinicalTrials.gov

Subarachnoid Bupivacaine in Obese Patients Undergoing Cesarean Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

May 30, 2018

Conditions
Anesthesia, Obstetrical
Interventions
DRUG

Bupivacaine 5 mg

Receive subarachnoid hyperbaric bupivacaine at a dose of 5 mg

DRUG

Bupivacaine 10 mg

Receive subarachnoid hyperbaric bupivacaine at a dose of 10 mg

Trial Locations (1)

44280

Hospital Civil de Guadalajara, Guadalajara

All Listed Sponsors
lead

Hospital Civil de Guadalajara

OTHER

NCT04205344 - Subarachnoid Bupivacaine in Obese Patients Undergoing Cesarean Delivery | Biotech Hunter | Biotech Hunter